PatientTrac Companion | Reimbursement Series

The remittance file opens to a column of identical lines: MEOS, one beneficiary, one month, $110.00. The practice's finance lead scrolls. The same line repeats for every patient mid-chemotherapy. A handful read $140.00 instead. Nobody on the infusion floor has ever seen this page.
Each of those lines is a Monthly Enhanced Oncology Services payment, and every one carries obligations the practice must meet.
The Enhancing Oncology Model is run by the CMS Innovation Center. It covers individuals receiving systemic cancer treatment for seven cancer types: breast cancer, chronic leukemia, small intestine/colorectal cancer, lung cancer, lymphoma, multiple myeloma, and prostate cancer. For patients dually eligible for Medicare and Medicaid, the total payment rose from $100 to $140 per month. EOM added a second cohort starting July 1, 2025, and the model now concludes on June 30, 2030, for both cohorts.
The payment funds specific services. CMS describes them as round-the-clock access to a clinician, patient navigation, and comprehensive care plans that support shared decision-making between the patient and the care team. Practices must also screen for health-related social needs, focusing at a minimum on food insecurity, transportation, and housing.
A second condition shapes every participating practice's economics. EOM participants are responsible for the total cost of care, including drugs, during each attributed episode. Only the additional $30 for dually eligible patients is excluded from that total-cost-of-care responsibility. The base $110 is not free money. It counts against the practice's own spending benchmark, so the services it pays for have to lower costs to justify themselves.
That changes what a practice should ask of any patient-engagement tool. The question is whether the tool helps deliver navigation, care planning, social-needs screening, and after-hours access, and then proves those services happened, month after month, across every attributed patient.
PatientTrac Companion is built around that list. Care-plan access, care-team messaging, navigation tracking, and HRSN screening all sit in the patient's hands and flow back into the practice's record. The $110 is paid to the practice. Companion's job is to make sure each of those remittance lines has a documented service behind it.
The finance lead's column will keep growing as more patients start treatment. The open question is how many of those lines the clinical floor could defend in an audit.
Primary Sources
- CMS Innovation Center — Enhancing Oncology Model
- CMS — EOM Frequently Asked Questions
- CMS — EOM Second Cohort Fact Sheet
Explore the Remote Care Perspectives Series
- Section overview
- 1. "Does Medicare Pay for This App?" Is the Wrong Question
- 2. What $110 a Month Actually Buys in Oncology
- 3. CMS Requires ePROs but Doesn't Pick Your Vendor
- 4. The 2 A.M. Call
- 5. Why Typing Your Symptoms Isn't Remote Monitoring
- 6. The Short-Burst Recovery Window
- 7. Minutes Are Money, If You Can Prove Them
- 8. Canada: Ten Provinces, Ten Rulebooks
- 9. The NHS Doesn't Bill. It Commissions.
- 10. Reimbursement as a Feature, Not a Promise


